It is not approved for any use as of June 2026, so eligibility is defined by the trials, not by a label
The transformative potential is evident in specific contexts: for patients with high cardiovascular risk, substantial obesity, and access to comprehensive care, including nutritional support, GLP-1 agonists offer unprecedented therapeutic benefits
That said, fiber-rich foods (legumes, oats, onions, Jerusalem artichoke), higher-protein meals, and fermented foods can each modestly support your body's own GLP-1 and satiety signaling through the microbiome and L-cell pathways described above
The compounding question is covered in more depth in our semaglutide guide
The body's response is predictable: cortisol goes up, water retention increases, sleep quality drops, and fat loss stalls
Semaglutide slows down digestion, leading to increased burping, gas, and other gastrointestinal symptoms, particularly during dose adjustments or dietary changes